@article{38875782eceb48f7a8b897ade4a45e4a,
title = "Lack of Clinical Benefit of Interferon β-1a among Patients with Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?",
author = "Manu Shankar-Hari and Calfee, {Carolyn S.}",
note = "Funding Information: Conflict of Interest Disclosures: Dr Calfee reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study and grants and personal fees from Roche/Genentech and Bayer, grants from GlaxoSmithKline, and personal fees from CSL Behring and Quark outside the submitted work. No other disclosures were reported. Funding Information: Funding/Support: Dr Shankar-Hari is supported by the National Institute for Health Research Clinician Scientist Award (CS-2016-16-011). Dr Calfee is supported by NIH grant HL140026. ",
year = "2020",
month = feb,
day = "25",
doi = "10.1001/jama.2019.22524",
language = "English",
volume = "323",
pages = "713--715",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "8",
}